TL;DR: Three rules will keep a cosmetic-dermatology Instagram account out of trouble in 2026: avoid FDA-flagged outcome language (no "guarantees," "cures," "permanent"), disclose any partnership or paid recommendation per FTC endorsement guides, and use signed patient-image consent for every before-and-after — not a one-time blanket consent.
The compliance question for dermatology Instagram is not abstract. The FDA issues warning letters to medical practices that overstate product or treatment outcomes; the FTC pursues practices that fail to disclose paid endorsements. Both have done so multiple times in the past three years.
Below is a working checklist a cosmetic-derm account can use to audit its content.
What FDA language should a dermatologist avoid on Instagram?
The FDA's warning letter database shows a clear pattern across recent enforcement actions: outcome claims phrased as guarantees, cures, or permanent results draw the most regulatory attention.
Specifically avoid:
- "Guaranteed results" or "we guarantee"
- "Cures acne" / "cures rosacea" / "cures melasma" (cosmetic procedures and over-the-counter products do not cure these conditions)
- "Permanent" applied to filler, laser, or topical treatments
- "Pain-free" applied to procedures with any documented discomfort
- "FDA-approved" without specifying exactly which device or substance
- "Safe for everyone" or "no side effects"
Mintdrop's caption-generation pipeline has a compliance scan that flags these terms; the same list works as a manual audit checklist. The American Academy of Dermatology maintains additional patient-communication guidance with similar phrasing rules.
A small note on tone: it is fine to be specific about what a treatment does in clinical terms (e.g., "tretinoin increases epidermal turnover, which can improve fine lines over 12-16 weeks"). The compliance issue is unqualified outcome promises, not honest mechanism descriptions.
What FTC rules apply to a derm's product recommendations?
The FTC's Endorsement Guides require clear and conspicuous disclosure of any material connection between the endorser and the product. For a cosmetic-dermatology practice, "material connection" includes:
- Receiving the product for free
- Receiving payment for the recommendation
- A practice-product partnership (white-label, exclusivity, revenue share)
- A practice-owner stake in the brand
The required disclosure is "clear and conspicuous" — that means visible in the first caption-fold (the part shown before the "more" cutoff), not buried at the bottom. The standard phrase patterns the FTC has accepted:
- "Paid partnership with [brand]"
- "Sponsored by [brand]"
- "[Brand] sent me this; here's what I think"
- "I am paid to recommend [brand]"
What the FTC has explicitly rejected:
- "#ad" alone in a long hashtag list
- "Thanks to [brand] for the gift" without a disclosure tag
- Disclosures in Stories that disappear before the post does
Instagram's built-in "paid partnership" tag is a separate mechanism. Using it does not eliminate the FTC requirement to disclose the relationship in the caption — but using both is the cleanest approach.
Q: How should a derm handle before-and-after photo consent?
Three rules from practices doing this well:
- Use a per-image consent form, not a blanket "this practice may use my photos" consent. The patient signs once per posted image and indicates which platforms the image is approved for.
- Include disclosure language directly on the post: "Patient consented. Individual results vary."
- For minors (under 18), parental consent is required and the post should not include identifying features beyond the clinical area being shown.
The AAD's practice-resource library includes a consent-form template that is a reasonable starting point. ASPS has a more detailed version for surgical practices that some derm offices adapt.
Q: Can a dermatologist share patient stories without showing the patient?
Yes, and this often works better than image-based content. The "hands and materials" angle (a Reel of a treatment in progress with no face visible) and the editorial single ("here is what I tell every melasma patient") both convert well without consent overhead.
A frank, anonymized clinical breakdown of a tough case ("the patient I almost referred out, and why I didn't") routinely outperforms a before-and-after carousel in saves and DMs — and it sidesteps the consent question entirely.
Q: What words should appear in every derm post about a prescription topical?
A short clinical context block. The phrasing the AAD recommends, paraphrased:
- "Prescription strength" rather than "the strongest"
- "May cause [specific side effect]" rather than "may have side effects"
- "Speak with your dermatologist about [condition] before starting" rather than "ask your derm if it's right for you"
Specificity reads as trustworthy. Vagueness reads as marketing copy.
Q: How should a derm respond to a patient comment that mentions a competitor?
Either delete it (with no public response) or reply with a generic professional note that does not name the competitor. The FTC has not pursued these cases aggressively, but practice-management cases have established that publicly disparaging another practice via social comments is professionally hazardous.
The cleanest reply pattern: "We can't speak to other practices' protocols. We are happy to share ours — DM us if you'd like to talk through it."
Q: Is it compliant for a derm to show product before-and-afters on Instagram?
Conditional yes — with three guards. First, the product must be FDA-cleared or FDA-approved for the indication you're showing (over-the-counter cosmetics have a lower bar but still require honest labeling). Second, the post must disclose any material connection to the product. Third, individual-results-vary language should appear in the caption.
The FTC's Health Products Compliance Guidance is the authoritative reference; the FDA's cosmetics labeling guidance covers the product-side rules.
The five-line audit
A practice can audit any single Instagram post in five lines:
- Is there an outcome guarantee, "cure," or "permanent" claim? (Remove.)
- Is there a paid partnership or product gift not disclosed in the first caption-fold? (Add the disclosure.)
- If patient images, is there a per-image signed consent on file? (Confirm.)
- If a prescription topical or device is named, is the indication accurate and the side-effect language present? (Add.)
- If a competitor is named or alluded to, can it be removed without losing the post's point? (Remove.)
A practice that runs this audit weekly is several standard deviations safer than one that does not.
What to do this week
Pick the most recent five posts on the account. Run the five-line audit. Edit or remove anything that fails. Keep the audit checklist near the publishing tool — the cost of catching one issue before posting is far lower than the cost of an FDA or FTC inquiry.
Last updated: 2026-05-14.
Sources: US Food and Drug Administration, Federal Trade Commission Endorsement Guides, American Academy of Dermatology.